Eris Lifesciences trades lower after buying branded formulation business of Biocon Biologics
Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930. Read More Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930. Broking house Motilal Oswal maintained neutral… Read More »Eris Lifesciences trades lower after buying branded formulation business of Biocon Biologics







